Lensvector
USPTO PatentsView assignee record - 37 granted patents across 19 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica).
The verdict
According to USPTO PatentsView, Lensvector ranks #8,630 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 19 technology areas.
- #8,630
- of 49,997 US assignees by volume
- Top 33%
- by Innovation Score (41.5/100)
- 20.4
- avg claims per patent
- -72%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8630 · US Corporation #8,630 · 37 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 37 grants
- UPPER-Q #8,630/49,997
- PHOTO-FINISH Karyopharm Therapeut…
- CPC-FOCUS G02F · 19 areas
- INNOV-PAR 41.5/100
- CLAIMS-DENSE 20.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -72% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Karyopharm Therapeutics Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lensvector’s 41.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lensvector
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Innate Pharma · near
Innate Pharma · near
42 score
- Interaptix · near
Interaptix · near
42 score
- Lensvector · this assignee
Lensvector · this assignee
42 score
- Nissin Foods Holdings · near
Nissin Foods Holdings · near
42 score
- Technology Research… · near
Technology Research… · near
42 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lensvector's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lensvector?
Each dot is one of Lensvector’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lensvector’s own 20.4 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Lensvector's grants concentrate
Lensvector is a focused PatentsView assignee: 19 CPC subclasses with 83.8% of grants classified under G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2023. By volume, Lensvector sits between Karyopharm Therapeutics Inc. and Lenovo (United States) Inc..
Lensvector's three-year grant acceleration
Lensvector shows 2 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Lensvector's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Karyopharm Therap…
Karyopharm Therapeutics Inc.
37 patents
- Ketra
Ketra, Inc.
37 patents
- Khalifa Universit…
Khalifa University of Science, Technology and Research
37 patents
- Kite Pharma
Kite Pharma, Inc.
37 patents
- Leoni Bordnetz-sy…
Leoni Bordnetz-Systeme GmbH
37 patents
- Liebherr-aerospac…
Liebherr-aerospace Lindenberg GMBH
37 patents
- Lamplight Farms I…
Lamplight Farms Incorporated
37 patents
- Lenovo (United St…
Lenovo (United States) Inc.
37 patents
- Lensvector ◀
Lensvector
37 patents
What this shows Lensvector holds 37 patents at rank #8,627, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lensvector
By rank, the assignees closest to #8,627 in granted patent volume.
- Karyopharm Therapeutics Inc. #8,623 · 37 patents
- Ketra, Inc. #8,624 · 37 patents
- Khalifa University of Science, Technology and Research #8,625 · 37 patents
- Kite Pharma, Inc. #8,626 · 37 patents
- Leoni Bordnetz-Systeme GmbH #8,628 · 37 patents
- Liebherr-aerospace Lindenberg GMBH #8,629 · 37 patents
- Lamplight Farms Incorporated #8,630 · 37 patents
- Lenovo (United States) Inc. #8,631 · 37 patents
Leaders in G02F (Optical Devices OR Arrangements FOR THE Control OF Light…)
Other assignees with the most granted patents in Lensvector's primary technology class.
- Samsung Electronics Co., Ltd. 5,656 in class
- BOE Technology Group Co., Ltd. 4,930 in class
- Japan Display Inc. 3,130 in class
- LG Display Co., Ltd. 1,653 in class
- Sharp Kabushiki Kaisha 1,589 in class
- Tencent Technology (SHENZHEN) Company Limited 1,457 in class
- Semiconductor Energy Laboratory Co., Ltd. 1,397 in class
- Beijing BOE Optoelectronics Technology Co., Ltd. 848 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Lensvector, neither rank-band nor same-CPC leaders (those blocks stay above). In G02F (Optical Devices OR Arrangements FOR THE Control OF Light…), Lensvector ranks #124 of 1,354 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (42 here).
Lensvector's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 33% higher than 67% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 18.9% |
| 2016 | 8 | 21.6% |
| 2017 | 4 | 10.8% |
| 2018 | 6 | 16.2% |
| 2019 | 4 | 10.8% |
| 2020 | 3 | 8.1% |
| 2021 | 3 | 8.1% |
| 2023 | 1 | 2.7% |
| 2024 | 1 | 2.7% |
Which technologies does Lensvector patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lensvector's patent record in context - here's where to go next.
- Lensvector's lead technology class is G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica), 83.8% of its portfolio - see every assignee active in that class. Explore G02F
- Ranked #8,630 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lensvector against Karyopharm Therapeutics Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.